B2B SaaS M&A FAQ

Private Equity dominates with roughly 70% of deals, strategics account for about 20%, and other buyers (family offices, search funds) make up the remaining 10%. This surprises many founders who assume strategics are the primary buyer.

No. While strategics can sometimes pay more due to larger balance sheets and synergies, they’re often incentivized to pay as little as possible. Corporate development teams get rewarded for being “disciplined acquirers.” A strategic buyer who thinks you’re desperate for an exit may actually lowball you compared to PE buyers.

Strategic deals are personality-driven. They happen because someone inside—an SVP, GM, or rising executive—wants them to happen. If that internal champion gets fired, promoted, leaves, or loses political capital, your deal can evaporate overnight. Strategic deals are never more than 50/50 to close, even the day before closing.

Tuck-in buyers are PE firms acquiring you to bolt onto an existing portfolio company. Platform buyers are acquiring you as a standalone foundation they’ll build around with future acquisitions. Tuck-ins move faster and often pay strategic premiums for the right fit. Platform deals may offer more rollover equity and longer-term involvement for founders.

Tuck-ins are “deal-strategic”—they buy with strategic logic but without corporate bureaucracy. They have deal teams, governance processes, and capital earmarked for exactly this type of acquisition. When the fit is strong and synergies are clear, they can move fast and pay up without getting tangled in internal politics.

It varies by fund size. Smaller funds (<$300M AUM) may consider $2–5M ARR. Mid-sized funds ($300M–$1B AUM) typically want $10–20M ARR+. Larger funds (>$1B AUM) generally won’t look below $50M ARR unless growth is exceptional. Growth rate matters as much as scale—a $5M company growing 70% might qualify where a $20M company growing 5% won’t.

Value buyers include turnaround specialists (who fix broken companies), cigar-butt buyers (who acquire for 1–2x ARR and run lean for cash flow), and buyers looking for “steals” (below-market deals). There’s nothing inherently wrong with these buyers if timing and goals align, but if you’re growing well, you shouldn’t be priced like a distressed asset. If you are, something’s wrong with your process.

Search funds (ETA buyers) typically have small capital pools and investors who understand service businesses, not SaaS metrics. They’re usually uncomfortable with high-multiple, high-growth assets and propose deal structures (heavy seller financing, aggressive earnouts) that don’t make sense for SaaS. They can’t match the valuation, speed, or sophistication of experienced PE or strategic buyers.

Everyone says they’re “founder-friendly.” Strategics, PE funds, value buyers, and opportunistic holdcos all use the same language. What matters isn’t what they say—it’s which game they’re actually playing. A 3x offer from a value buyer may sound fine until you realize another buyer type would have paid 6x. Focus on understanding buyer motivations, not their marketing.

The biggest mistake is running an informal, one-buyer-at-a-time process. The sub-$20M ARR M&A market is opaque and unstructured. If you only talk to value buyers, you’ll start to believe their version of “market.” Run a disciplined process that tests the full buyer landscape—strategics, tuck-ins, platform buyers—to surface the true market clearing price.

Buyers aren’t generic. Each type sees your business through a different lens with different constraints, incentives, and politics. Your job—or your banker’s—is to understand not just what your company is worth, but who it’s worth that much to. That’s the real art of SaaS M&A: mapping the landscape and running a process that surfaces the right buyers.

Corporate development (corp dev) is the team inside a large company responsible for finding and executing acquisitions. They evaluate hundreds of targets per year but close very few. Importantly, corp dev teams are incentivized to pay as little as possible—their bonuses and reputations depend on being seen as “disciplined acquirers,” not generous ones. When a corp dev team reaches out, remember: they are professional buyers negotiating against you, a likely first-time seller.

Rollover equity means reinvesting a portion of your sale proceeds—typically 10–40%—into the acquiring entity’s equity rather than taking all cash at closing. It’s most common in Private Equity deals, especially platform acquisitions, where the buyer wants you to have “skin in the game” and share in future upside. If the PE firm later sells the combined entity at a higher multiple, your rollover stake can be worth significantly more than the cash you gave up—but it’s not guaranteed.

Multiple expansion is when a buyer acquires your company at one valuation multiple (say 5x ARR) and later sells the combined entity at a higher multiple (say 8x ARR). The difference is pure value creation without growing the underlying business. PE firms love tuck-in acquisitions partly because combining your niche product with their larger platform can justify a higher exit multiple for the whole entity. This “1+1=3” effect is one reason tuck-in buyers sometimes outbid strategics.

Don’t signal eagerness. When you ask to be acquired or appear too willing to exit, you anchor yourself as a low-price target. Corp dev teams will assume you’re looking for a way out and adjust their offer downward. Instead, acknowledge interest politely but don’t engage in a one-buyer-at-a-time conversation. Get an experienced M&A advisor who can test the broader market and create competitive tension. An unsolicited offer is a data point, not a baseline for your company’s value.

It depends on the deal type. In platform acquisitions, founders often stay on as CEO, lead future tuck-in acquisitions, and participate meaningfully in the PE firm’s eventual exit—making it potentially career-expanding rather than a “sell out.” In tuck-in deals, the transition period is usually shorter, and your role may be absorbed into the existing platform’s leadership. In either case, the specifics—title, authority, earn-out conditions, and time commitment—are negotiated as part of the deal and should be addressed explicitly in the LOI.

Constellation Software (CSI) is a Canadian public company that has built a multi-billion-dollar empire by acquiring thousands of small vertical SaaS businesses at modest multiples—typically 1–2x ARR—and holding them indefinitely. They’re the archetypal “cigar-butt” buyer in SaaS: disciplined, long-term focused, and rational, but they don’t pay premium prices and won’t chase your deal if there’s competitive tension. If Constellation or one of its operating groups (Volaris, Harris, etc.) approaches you, know that their offer likely reflects the bottom of your valuation range, not the market clearing price.

It depends on your growth rate, retention, profitability, and buyer mix. Rough ranges for $2–20M ARR B2B SaaS: companies growing >50% with strong retention can trade at 7–12x ARR; moderate growth (25–50%) with solid fundamentals trades at 4–6x ARR; low growth (<25%) typically clears 1–3x ARR. But these are just ranges—your actual multiple depends heavily on which buyers are at the table and how your process is run.

ARR stands for Annual Recurring Revenue—the annualized value of your recurring subscription contracts. It’s the primary metric buyers use to value SaaS businesses because it represents predictable, repeating cash flow. Enterprise value in SaaS M&A is typically expressed as a multiple of ARR (e.g., “5x ARR”). Non-recurring revenue (services, one-time fees) is valued separately and at much lower multiples.

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It’s a proxy for operating profitability—how much cash the business generates from operations. SaaS buyers care because profitability changes your buyer pool: a profitable SaaS company unlocks debt financing for acquirers, which lets them pay more. Crossing into consistent profitability (25%+ EBITDA margin) can add multiple turns to your valuation.

GRR measures how much recurring revenue you keep from existing customers before counting expansion or upsells. For B2B SaaS, 90–95%+ GRR is elite, 80–90% is strong, 70–80% is marginal, and below 70% is problematic. High GRR tells buyers your product is embedded in customer workflows and painful to rip out—which makes the revenue you’re selling them durable and predictable.

NRR measures revenue from existing customers including expansion and upsells. NRR above 110% is exceptional—it means your revenue grows even without new customers. Around 100% is solid. Below 85% signals weak pricing power or product gaps. Strong NRR tells buyers your market has headroom and your pricing model works, directly lifting your multiple.

Growth is the single most important valuation driver. There’s a discontinuity below 25% YoY growth where the buyer universe shrinks dramatically and valuation can halve. At 25–50% growth, you’re in the 4–6x range. At 50–100%, you’re in competitive auction territory (7–9x). Above 100%, buyers stretch multiples to win (10x+). Importantly, the shape of the growth curve matters as much as the number—consistent compounding is far more valuable than one-off spikes.

LTV/CAC (Lifetime Value divided by Customer Acquisition Cost) measures go-to-market efficiency. Above 10x means your engine mints money. In the 4–8x range, more capital can probably accelerate growth. Below 2x, you’re burning cash faster than you’re building value. Buyers use it to judge whether growth is scalable—can they pour in more marketing dollars and expect proportional returns?

Significantly. If your top 10 customers represent more than 30–40% of ARR, buyers will discount your valuation or demand earnouts. Above 50%, expect major valuation pressure. A $10M ARR company with 90% GRR but 60% revenue from two clients might trade below a $5M ARR peer with balanced exposure. Multi-year contracts, mission criticality, and zero historical churn among top accounts can offset concentration risk somewhat.

Generally yes. Vertical SaaS (software built for a specific industry like dental, construction, or veterinary) repeatedly trades at premium multiples (8–10x ARR+) because switching costs are enormous. If your product runs payroll, scheduling, and compliance for a niche industry, buyers see you as owning that industry’s workflow. Horizontal tools (scheduling, email marketing) typically trade at 3–5x because they’re more easily replaced.

Score yourself across the key valuation levers: ARR growth, GRR, NRR, EBITDA margin, gross margin, LTV/CAC, customer concentration, market momentum, and team depth. If most are “strong,” you’re likely a premium asset (8–12x ARR). Mostly “neutral” puts you at market range (5–7x). Multiple weak flags means value-buyer pricing (1–4x). The key insight: start optimizing these levers a year before going to market—founders who do almost always clear at the top of their range.

Buyers price what they can verify, not what you promise. A slower-growing company with airtight retention and 30% EBITDA margins will almost always clear higher than a rocket ship with 60% churn. The former is a financial asset; the latter is a gamble. This is different from venture capital, where investors fund potential. In M&A, every ambiguity adds a discount and every proof point adds a premium.

The most common: comparing to venture fundraising headlines (VCs price future potential, acquirers price current reality), overweighting anecdotes (“my friend sold for 10x” — but maybe with no cash and an impossible earnout), only talking to value buyers and believing their offers represent “market,” confusing strategic interest with certainty to close, and chasing unattainable premiums like seeking 10x on 25% growth.

Enterprise value is the headline number in an offer—but it’s not your payout. Your actual proceeds equal EV minus debt payoffs, transaction fees, escrow holdbacks, and working capital adjustments, plus any cash in the company. A $50M EV offer might net you $35–40M after deductions. Always focus on net proceeds, not the headline.

In B2B SaaS deals between $2–20M ARR, cash at close typically represents 50–80% of the headline enterprise value. Anything above 80% is excellent and usually means you ran a competitive process. Below 50% should give you pause unless the non-cash components (rollover equity, earnout) are genuinely attractive and achievable.

An earnout is a contingent payment tied to future performance metrics—usually revenue, ARR, or EBITDA targets. Despite the common advice to “assume earnouts are worthless,” well-designed earnouts can be valuable. The key is structure: a single seller-influenceable metric on a sliding scale (not a binary cliff), with acceleration on termination without cause and clear measurement provisions. Poorly designed earnouts with multiple conflicting hurdles and buyer-controlled levers rarely pay out.

In a stock sale, the buyer acquires your company’s shares. In an asset sale, they cherry-pick specific assets. Stock sales are almost always better for founders: proceeds get capital gains treatment, and you may be eligible for QSBS (Qualified Small Business Stock) exemption. Asset sales can trigger double taxation for C-Corps—once at the corporate level and again when proceeds are distributed. If a buyer proposes an asset deal, discount that offer by the additional tax burden when comparing to stock deal offers.

QSBS (Qualified Small Business Stock) is a federal tax provision that can exclude up to $10M (or 10x your basis) of capital gains from taxation when selling C-Corp stock held for five or more years. In a clean stock sale, this can mean 0% federal tax on your proceeds. An asset sale or retention bonus converts those same proceeds into ordinary income at up to 37%. The difference can be millions of dollars—make sure your deal is structured to preserve QSBS eligibility.

An escrow holdback is a portion of the purchase price—typically 10–15%—held by a neutral third party for 12–18 months after closing. It covers potential indemnification claims if the representations and warranties you made about the business turn out to be false. For larger deals ($25M+ EV), Representations and Warranties Insurance (RWI) can replace most of the escrow, reducing the holdback to just 1–2%.

Working capital is the cash required to operate your business day-to-day. At closing, the buyer compares your actual working capital to a “target” (usually based on a trailing 12-month average) and adjusts the purchase price accordingly. For SaaS businesses with annual prepaid subscriptions, deferred revenue creates particular complexity. Working capital disputes often emerge late in the deal process and can involve hundreds of thousands of dollars. Don’t agree to excess net working capital targets, and make sure your banker advocates strongly based on historical data.

A seller note is debt you extend to the buyer—you’re financing part of your own acquisition. They typically carry 5–8% interest over 2–5 years. Seller notes are uncommon in deals over $20M but appear in smaller deals or when buyers are stretching to hit valuation targets. If you must hold one, negotiate like a lender: demand security against assets, seniority over other debt, acceleration on change of control, and clear default provisions.

Structure determines real value. A $54M offer with 50% cash, 20% rollover, and a 30% earnout tied to aggressive growth targets can have a lower expected present value than a $45M offer with 80% cash and 20% rollover. The difference comes from time value of money, probability of earnout achievement, and risk on the rollover. Always model expected total proceeds using realistic assumptions about earnout likelihood and equity outcomes.

Taxation depends on deal structure. In a stock sale, proceeds are generally taxed at capital gains rates (currently 20% federal for long-term gains), and QSBS may exclude up to $10M entirely. In an asset sale, C-Corps face double taxation. Retention bonuses and employment-based earnouts are taxed as ordinary income (up to 37%). Rollover equity can be tax-deferred if structured properly as a 351 exchange. The tax difference between a well-structured and poorly-structured deal can be 15–30% of your proceeds.

No. Most successful exits are the result of deliberate, well-executed sale processes. Founders decided to sell, hired a banker, ran a competitive process, and extracted real value from the market. The companies that get “bought” without trying are the exception, not the rule. This advice usually comes from VCs who want you to keep building or founders who got extraordinarily lucky.

When your growth rate is still strong and you don’t have another growth curve you believe in. Growth naturally decays—on average, next year’s growth rate is about 85% of this year’s. A $6M ARR company growing 40% is often worth more than an $8M ARR company growing 20%. If you don’t have the energy or conviction for another growth initiative, sell while momentum is intact. Don’t wait for growth to decay and your leverage to disappear.

Three thresholds create step-changes in buyer interest: $2M ARR (the floor for institutional interest), $5M ARR (opens up lower mid-market PE; roughly doubles your buyer pool), and $10M ARR (activates mid-market PE platform buyers and serious strategic interest). The jumps from $4M to $5M and $9M to $10M matter more than $5M to $6M or $10M to $11M. But don’t sacrifice growth to hit a number—a $5M company growing 50% is worth more than an $8M company growing 15%.

If breakeven is 6–9 months away and achievable without gutting growth, yes. Profitability transforms your buyer pool: it unlocks debt financing for acquirers (so they can pay more), removes the “needs post-close capital” discount, and signals operational maturity. A company doing $6M ARR at 25% growth and 15% EBITDA margin will often trade higher than one doing $8M ARR at 35% growth and −10% EBITDA. The profitable company is a financial asset. The unprofitable one is a bet.

The valley of death is the space between two viable states: growing fast enough to raise more capital (100–200%+ growth) and profitable enough to be an attractive acquisition (breakeven or better). Companies in the middle—burning cash, growing 30–80%, not fast enough for VCs, not profitable for buyers—have few good options. If you see yourself drifting toward the valley, act before you get there: either go for growth hard (hail mary) or cut to profitability hard. The middle path leads to the worst outcomes.

Generally no. While multiples do fluctuate (SaaS traded at 10x in 2021, compressed to 6x in 2022), the math often washes out. If you sell at a lower multiple in a down market, your reinvestment opportunities are also cheaper. And while you’re waiting for “the market to come back,” your company-specific factors are changing—growth is decaying, competitors are emerging, your energy is flagging. Time your readiness, not the market.

This is the single most common timing mistake founders make. A founder at $6M ARR growing 40% decides to wait and hit $8M. They get there 12 months later but growth has decelerated to 20%. The $6M company at 40% growth (worth ~$42M at 7x) was worth more than the $8M company at 20% growth (worth ~$24M at 3x). Chasing an extra $2M of ARR while growth decayed cost them $18M in enterprise value. Growth dominates valuation—once it starts decelerating, every quarter of delay can destroy value.

No. Half-assing it—taking every call, entertaining exploratory conversations, sharing metrics with anyone who asks—is the worst of both worlds. You’re distracted from running your business, leaking information to potential competitors, and anchoring yourself as eager to sell. Either be not for sale (ignore inbound, focus on building) or commit to a real sale process (hire a banker, create competitive tension). The founders who get hurt are the ones in the middle.

The decision is fundamentally psychological. Ask yourself: do you have energy for another 3–5 years of stacking growth curves? Are you excited about the next phase, or exhausted? Are there personal circumstances pushing you toward liquidity—burnout, family, a new idea, co-founder dynamics? Some founders optimize ruthlessly for maximum value; others know they’re done and are fine leaving some money on the table. Both are legitimate. What matters is being honest with yourself about which one you are.

A well-run competitive process typically takes 4–6 months from kickoff to close: 4–6 weeks of preparation, 2–3 weeks of outreach, 3–4 weeks of engagement and management meetings, and 6–10 weeks of due diligence and closing. Timeline can stretch longer if preparation is inadequate, if the buyer is slow, or if due diligence uncovers surprises. The key is maintaining momentum—“time kills all deals.”